Trends in hypertension prevalence, awareness, and treatment among middle-aged and older adults in China, 2011-2015 [0.03%]
中国中老年人高血压患病率、知晓率和治疗率的变化趋势(2011—2015年)
Kaili Lu,Qiaoling Zhou,Guozhong Xue
Kaili Lu
Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort" [0.03%]
关于“胰腺导管腺癌改良FOLFIRINOX方案初始相对剂量强度的优化:一项多中心队列研究”的评论回复
I-Wei Ho,Chung-Pin Li,Shih-Hung Yang et al.
I-Wei Ho et al.
Comment on: "Intratumoral microbiome composition and its role in tumor recurrence in primary liver cancer" [0.03%]
关于“肝癌瘤内微生物群组成及其在肿瘤复发中的作用”的点评
Junyong Fan,Ying Ye,Wei Xia
Junyong Fan
Response to the comment on "Machine learning-based prediction of CAC-defined cardiovascular risk using routine health examination dataˮ [0.03%]
关于“基于机器学习的使用常规健康检查数据预测CAC定义的心血管风险”的评论回复
Shan-Shan Chuang,Fu-Tien Chiang,Shih-Wei Lin
Shan-Shan Chuang
Response to Letter to the Editor regarding "2025 Taiwan consensus recommendations for primary care of chronic kidney disease" [0.03%]
关于“2025年台湾慢性肾脏病初级保健共识声明”的来信答复
Yi-Chun Tsai,Tai-Shuan Lai,Chih-Chien Sung et al.
Yi-Chun Tsai et al.
Application of endoscopic ultrasound in lower gastrointestinal subepithelial lesions [0.03%]
内镜超声在消化道黏膜下病变中的应用进展
Xiaoxiao Dong,Xumeng Ding,Haixia Lyu
Xiaoxiao Dong
Comment on "Alzheimer's disease diagnosis: An update and review of biomarkers, positron emission tomography, and emerging therapies" [0.03%]
关于“阿尔茨海默病诊断:生物标志物、正电子发射断层扫描及新兴疗法的更新与综述”的评论
Nand Kishor Prasad Sah,Shikha Saxena,Devansh Desai
Nand Kishor Prasad Sah
Author reply to letter to the editor "Comment on: Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease?" [0.03%]
代谢相关脂肪性肝病亚型流行率及临床结局?--致编辑信的作者回复
Yu-Ming Cheng,Chia-Chi Wang
Yu-Ming Cheng